Retinol-binding protein 4 is positively associated with bone mineral density in patients with type 2 diabetes and osteopenia or osteoporosis
Clinical Endocrinology May 16, 2018
Huang N, et al. - Experts scrutinized the connection between serum retinol binding protein 4 (RBP4), bone mineral density (BMD) and other bone metabolic-related parameters in patients with type 2 diabetes older than 50 years, with or without osteopenia or osteoporosis. From December 2015 to March 2017, patients with type 2 diabetes, hospitalized in the Endocrinology Department of Yantai Yuhuangding Hospital were recruited. Compared with normal bone mineral density group of type 2 diabetic patients, serum RBP4 was positively associated with BMD at all sites after adjustments for other factors in osteopenia and osteoporosis groups.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries